Biogen Pharmachem Industries Limited (BOM:531752)
India flag India · Delayed Price · Currency is INR
0.3700
-0.0200 (-5.13%)
At close: May 20, 2026

BOM:531752 Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
8.6-2.9319.314.56-0.09
Other Operating Activities
0.97----0
Change in Accounts Receivable
----25.4
Change in Accounts Payable
---18.4-0.61
Change in Other Net Operating Assets
6.12-7.890.14-5.91-10.73
Operating Cash Flow
15.68-10.8219.4517.0413.98
Operating Cash Flow Growth
--14.09%21.89%-64.60%
Investment in Securities
-89.38-184.0134.1-1925.39
Investing Cash Flow
-95.63-326.19-20.56-16.59-13.23
Issuance of Common Stock
63357---
Financing Cash Flow
63357---
Miscellaneous Cash Flow Adjustments
-0--0--
Net Cash Flow
-16.9519.99-1.120.460.76
Levered Free Cash Flow
12.09-9.582.2511.2716.58
Unlevered Free Cash Flow
12.09-9.582.2511.2716.58
Change in Working Capital
6.12-7.890.1412.4914.07
Source: S&P Global Market Intelligence. Standard template. Financial Sources.